Estrogen fights urinary infection in mice

WASHINGTON U.-ST. LOUIS (US) — Estrogen appears to reduce the risk of urinary tract infections, say researchers who studied the effect in mice.

The findings could help explain the increased risk of infections after menopause.

“Scientists tested estrogen as a treatment for post-menopausal women with urinary tract infections in the 1990s, but the results were either ambiguous or negative,” says senior author Indira Mysorekar, assistant professor of obstetrics and gynecology and of pathology and immunology at Washington University in St. Louis.

“With the mouse model of menopause that we’ve created, we can more completely understand how estrogen levels affect infection susceptibility, bladder health, and the inflammatory response to infection. That should point the way to better treatment strategies.”


Urinary infections are a significant cause of illness in many women throughout their lives and are particularly prevalent after menopause. The bacteria that cause these infections can spread to the kidney and bloodstream, with the potential for serious complications.

For the study published online in Infection and Immunity, scientists simulated menopause in mice by surgically removing their ovaries. Like menopausal women, the mice no longer make estrogen.

To rule out the possibility that the stress of surgery affects the risk of urinary tract infections, the researchers conducted the same surgery in other mice but put the ovaries back in, maintaining their ability to make estrogen.

When researchers gave both groups of mice urinary tract infections, the menopausal mice had higher levels of infectious bacteria in their urine. Most of the bacteria came from barrier cells, which line the interior of the bladder. These cells are the first to be infected by the bacteria.

“When the barrier cells are lost, they need to be replaced immediately,”” Mysorekar says. “In the menopausal mice, we found that this replacement process was stopping short of completion. That left cells under barrier cells exposed, and they are much more vulnerable to infection.”

The menopausal mice had more bacterial reservoirs, which are pockets of infection that may provide a place for the bacteria to hide during antibiotic treatment. After treatment stops, the reservoirs can reseed the infection.

In earlier research, Mysorekar had identified an important regulator of the barrier cell repair process. In the new study, she shows that low estrogen levels disable this regulator.

The bladders of the menopausal mice also had higher levels of immune inflammatory compounds known as cytokines.

“The cytokines caused inflammation that left the bladder in bad shape,” Mysorekar says. “It’s possible that damage caused by inflammation increases the bacteria’s ability to break into bladder tissue and create reservoirs of infection.”

In the control mice, which had normal estrogen levels, cytokine levels and inflammatory damage were both significantly lower. When researchers gave the menopausal mice estrogen, their cytokine levels and inflammatory damage also decreased significantly, as did reservoirs of infectious bacteria.

Earlier clinical trials of estrogen’s usefulness against urinary infection evaluated the treatment’s success by tracking levels of bacteria in the urine. The researchers say their new results suggest that bacteria levels alone may not provide a complete picture of estrogen’s effectiveness against the infections.

“If we can find ways to look at other aspects of the infectious process in humans, we may find that estrogen is more helpful than we previously realized,” Mysorekar says. “We need to look for other indicators, such as cytokines in the urine, to more fully assess estrogen’s potential role in treatment.”

Funding from the Center for Women’s Infectious Disease Research at Washington University and the Multiplex Gene Analysis Core of the Siteman Cancer Center supported this research.

Source: Washington University in St. Louis